Company Filing History:
3 out of 3 
1 out of 832,843 Years Active: 2017-2022
Title: Yu-Shan Wang: Innovator in Chronic Inflammation and Cancer Treatment
Introduction
Yu-Shan Wang is a prominent inventor based in Taipei, Taiwan. He has made significant contributions to the fields of medicine and biotechnology, particularly in the treatment of chronic inflammation and cancer. With a total of 4 patents, his work has the potential to impact many lives.
Latest Patents
Yu-Shan Wang's latest patents include innovative methods for treating conditions induced by chronic inflammation. One of his notable patents involves the use of metformin and sodium butyrate, which are disclosed as compositions and methods for addressing chronic inflammation. Another significant patent focuses on the use of an mTOR inhibitor and chloroquine for treating cancer. This patent outlines a medicament designed for cancer patients who do not respond to hormone therapy and immunotherapy, aiming to sensitize them to these treatments.
Career Highlights
Throughout his career, Yu-Shan Wang has worked with various organizations, including Johnpro Biotech Inc. His expertise in the field has led to advancements in therapeutic methods that address critical health issues.
Collaborations
Yu-Shan Wang has collaborated with notable professionals in his field, including Kwan-Hwa Chi and Chao-Chun Chang. These collaborations have contributed to the development of his innovative patents and research.
Conclusion
Yu-Shan Wang's contributions to medical innovation, particularly in chronic inflammation and cancer treatment, highlight his role as a leading inventor. His patents reflect a commitment to improving health outcomes through scientific advancement.